2017 annual financial data
Capricor Therapeutics 2017 Operating margin
Direct answer
Operating margin was -940.79%.
Operating income was -12,862,397 USD and net income was 2,431,423 USD.
Operating cash flow was -14,230,879 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,367,186 USD
- Operating income
- -12,862,397 USD
- Net income
- 2,431,423 USD
- Operating cash flow
- -14,230,879 USD